Cheng Andrew bought AKRO
September 10, 2025 · Form 4 insider transaction
Cheng Andrew bought 1,919 shares of Akero Therapeutics, Inc. at $19.87 per share, a transaction worth $38.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,919
Price
$19.87
Total value
$38.1K
InsiderCheng Andrew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 10, 2025
Filing dateSeptember 12, 2025
Shares owned after505,698
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 16, 2024, previously adopted by the Reporting Person.